Effect of Early and Delayed Commencement of Paricalcitol in Combination with Enalapril on the Progression of Experimental Polycystic Kidney Disease

Sagar, Priyanka S; Saravanabavan, Sayanthooran; Munt, Alexandra; Wong, Annette; Rangan, Gopala K.

doi:10.3390/jcdd8110144

Cited by 1 publication

(2 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A clinical trial of niacinamide (vitamin B) in patients with ADPKD showed no significant differences in primary outcomes 58 while studies on the effects of vitamin D and vitamin E have produced mixed results. [59][60][61] Supplements without Human Data in Patients with ADPKD BHB Given the potential benefits of ketogenic diet and challenges of long-term adherence, BHB combined with other supplements, such as citrate, have been developed. The safety and efficacy of these supplements have not been assessed or validated in patients with ADPKD.…”

Section: Vitaminsmentioning

confidence: 99%

See 1 more Smart Citation

Polycystic Kidney Disease Diet

Chebib,

Nowak,

Chonchol

et al. 2023

CJASN

View full text Add to dashboard Cite

Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by kidney cyst formation and progressive kidney function loss. Dietary interventions such as caloric restriction, intermittent fasting, and the ketogenic diet have recently emerged as potential strategies to induce metabolic reprogramming and slow ADPKD progression. We review the available evidence supporting the efficacy and safety of these interventions in ADPKD. Dietary interventions show promise in managing ADPKD by improving metabolic health and reducing oxidative stress. However, while preclinical studies have shown favorable outcomes, limited clinical evidence supports their effectiveness. Also, the long-term consequences of these dietary interventions, including their impact on adverse events in ADPKD patients, remain uncertain. To optimize ADPKD management, patients are advised to follow a dietary regimen that aims to achieve or maintain an ideal weight and includes high fluid intake, low sodium, and limited concentrated sweets. Caloric restriction appears particularly beneficial for individuals with overweight or obesity as it promotes weight loss and improves metabolic parameters. Supplementation with curcumin, ginkgolide B, saponins, vitamin E, niacinamide, or triptolide has demonstrated uncertain clinical benefit in ADPKD patients. Notably, beta-hydroxybutyrate (BHB) supplements have shown promise in animal models; however, their safety and efficacy in ADPKD require further evaluation through well-designed clinical trials. Therefore, the use of these supplements is not currently recommended for ADPKD patients. In summary, dietary interventions such as caloric restriction, intermittent fasting, and the ketogenic diet hold promise in ADPKD management by enhancing metabolic health. However, extensive clinical research is necessary to establish their effectiveness and long-term impacts. Adhering to personalized dietary guidelines, including weight management and specific nutritional restrictions, can contribute to optimal ADPKD management. Future research should prioritize well-designed clinical trials to determine the benefits and safety of dietary interventions and supplementation in ADPKD.

show abstract